Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 2
1994 4
1995 1
1996 1
1999 2
2000 1
2001 2
2002 3
2003 3
2005 7
2006 10
2007 5
2008 10
2009 14
2010 4
2011 11
2012 17
2013 21
2014 11
2015 17
2016 21
2017 14
2018 16
2019 17
2020 14
2021 14
2022 19
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

244 results

Results by year

Filters applied: . Clear all
Page 1
Genetic polymorphism in ERCC5 and breast cancer risk.
Shakil Malik S, Mubarik S, Baig M, Masood N, Chaudhry N. Shakil Malik S, et al. Mol Biol Res Commun. 2019 Mar;8(1):27-31. doi: 10.22099/mbrc.2019.32294.1383. Mol Biol Res Commun. 2019. PMID: 31528641 Free PMC article.
Single neuleotide polymorphism in ERCC5 were responsible for different cancers. Therefore, current study evaluated the relationship between ERCC5 (rs1047768 T>C) polymorphism and the risk of breast cancer in Pakistani population. ...Moreover, family …
Single neuleotide polymorphism in ERCC5 were responsible for different cancers. Therefore, current study evaluated the relatio …
Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer.
Yang G, Yang Y, Ma X, Huang L, Li W, Song X, Zhang H, Liu W, Lu J. Yang G, et al. Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820943244. doi: 10.1177/1533033820943244. Technol Cancer Res Treat. 2020. PMID: 32812509 Free PMC article.
INTRODUCTION: To explore association of excision repair cross-complementing 5 (ERCC5) genetic polymorphisms with cirrhosis and liver cancer. METHODS: A total of 365 patients were enrolled, including control group (n = 133), cirrhosis group (n = 122), and liver ca …
INTRODUCTION: To explore association of excision repair cross-complementing 5 (ERCC5) genetic polymorphisms with cirrhosis and liver …
Relationship of ERCC5 genetic polymorphisms with metastasis and recurrence of gastric cancer.
Wang S, Chen X, Fu Y, Zhang H, Liu W, Song X, Ma X, Cheng S, Lu J. Wang S, et al. Rev Assoc Med Bras (1992). 2021 Nov;67(11):1538-1543. doi: 10.1590/1806-9282.20210209. Rev Assoc Med Bras (1992). 2021. PMID: 34909875 Free article.
OBJECTIVE: This study aims to explore the role of ERCC5 genetic polymorphisms in gastric cancer and their relationship with metastasis and recurrence of gastric cancer. ...The relationship of ERCC5 genetic polymorphisms with metastasis and recurrence o …
OBJECTIVE: This study aims to explore the role of ERCC5 genetic polymorphisms in gastric cancer and their relationship with me …
The Association of ERCC1 and ERCC5 Polymorphisms with Lung Cancer Risk in Han Chinese.
Lan X, Li Y, Wu Y, Li X, Xu L. Lan X, et al. J Cancer. 2022 Jan 1;13(2):517-526. doi: 10.7150/jca.59277. eCollection 2022. J Cancer. 2022. PMID: 35069899 Free PMC article.
Results: The ERCC5 rs4771436 GG genotype, recessive model (GG vs. GT+TT), and the ERCC5 rs1047768 recessive model (CC vs. ...Conclusion: ERCC5 rs4771436 and rs1047768 genotypes were associated with an increased risk of lung cancer, suggesting that poly …
Results: The ERCC5 rs4771436 GG genotype, recessive model (GG vs. GT+TT), and the ERCC5 rs1047768 recessive model (CC vs. ...C …
Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings.
Bonache S, Esteban I, Moles-Fernández A, Tenés A, Duran-Lozano L, Montalban G, Bach V, Carrasco E, Gadea N, López-Fernández A, Torres-Esquius S, Mancuso F, Caratú G, Vivancos A, Tuset N, Balmaña J, Gutiérrez-Enríquez S, Diez O. Bonache S, et al. J Cancer Res Clin Oncol. 2018 Dec;144(12):2495-2513. doi: 10.1007/s00432-018-2763-9. Epub 2018 Oct 10. J Cancer Res Clin Oncol. 2018. PMID: 30306255
METHODS: We investigated a panel of 34 known high/moderate-risk cancer genes, including 16 related to breast or ovarian cancer (BC/OC) genes, and 63 candidate genes to BC/OC in 192 clinically suspicious of hereditary breast/ovarian cancer (HBOC) Spanish famil …
METHODS: We investigated a panel of 34 known high/moderate-risk cancer genes, including 16 related to breast or ovarian cancer …
ERCC5 rs751402 polymorphism is the risk factor for sporadic breast cancer in Thailand.
Pongsavee M, Wisuwan K. Pongsavee M, et al. Int J Mol Epidemiol Genet. 2018 Aug 20;9(4):27-33. eCollection 2018. Int J Mol Epidemiol Genet. 2018. PMID: 30245779 Free PMC article.
The real-time polymerase chain reaction (qPCR) was used to demonstrate genetic polymorphism of ERCC5. The results showed that the ERCC5 rs751402 polymorphism variant AG was associated with an increased risk of breast cancer. The frequency of ERCC5 rs75 …
The real-time polymerase chain reaction (qPCR) was used to demonstrate genetic polymorphism of ERCC5. The results showed that the …
Association between ERCC5 gene polymorphisms and breast cancer risk.
Na N, Dun E, Ren L, Li G. Na N, et al. Int J Clin Exp Pathol. 2015 Mar 1;8(3):3192-7. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26045839 Free PMC article.
We conducted a case-control study to evaluate the association between ERCC5 polymorphism and breast cancer risk. 325 breast cancer patients and 325 controls were recruited in our study between January 2011 and March 2014. ...In conclusion, our study indicated …
We conducted a case-control study to evaluate the association between ERCC5 polymorphism and breast cancer risk. 325 breast …
ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer.
Schultz CW, Zhang Y, Elmeskini R, Zimmermann A, Fu H, Murai Y, Wangsa D, Kumar S, Takahashi N, Atkinson D, Saha LK, Lee CF, Elenbaas B, Desai P, Sebastian R, Sharma AK, Abel M, Schroeder B, Krishnamurthy M, Kumar R, Roper N, Aladjem M, Zenke FT, Ohler ZW, Pommier Y, Thomas A. Schultz CW, et al. EMBO Mol Med. 2023 Aug 7;15(8):e17313. doi: 10.15252/emmm.202217313. Epub 2023 Jul 25. EMBO Mol Med. 2023. PMID: 37491889 Free PMC article.
Small-cell lung cancer (SCLC) is the most lethal type of lung cancer. Specifically, MYC-driven non-neuroendocrine SCLC is particularly resistant to standard therapies. ...High CDKN1A/p21 expression was associated with decreased synergy due to G1 arrest, while increa …
Small-cell lung cancer (SCLC) is the most lethal type of lung cancer. Specifically, MYC-driven non-neuroendocrine SCLC is part …
Role of ERCC5 polymorphisms in non-small cell lung cancer risk and responsiveness/toxicity to cisplatin-based chemotherapy in the Chinese population.
Li M, Chen R, Ji B, Fan C, Wang G, Yue C, Jin G. Li M, et al. Oncol Rep. 2021 Mar;45(3):1295-1305. doi: 10.3892/or.2021.7935. Epub 2021 Jan 14. Oncol Rep. 2021. PMID: 33469680
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide. ...However, rs4771436 in ERCC5 gene was significantly correlated with the reduced risk of toxicity. ...
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide. ...However, rs4771436 in ERCC5 …
Polymorphisms in ERCC4 and ERCC5 and risk of cancers: Systematic research synopsis, meta-analysis, and epidemiological evidence.
Zuo C, Lv X, Liu T, Yang L, Yang Z, Yu C, Chen H. Zuo C, et al. Front Oncol. 2022 Aug 11;12:951193. doi: 10.3389/fonc.2022.951193. eCollection 2022. Front Oncol. 2022. PMID: 36033436 Free PMC article.

We obtained 11 polymorphisms significantly related to changed susceptibility to 11 cancers (p < 0.05). Strong evidence was assigned to four variant-related cancer risks in Asians (ERCC4 rs744154 with bladder cancer, ERCC5 rs2296147 with esophageal

…

We obtained 11 polymorphisms significantly related to changed susceptibility to 11 cancers (p < 0.05). Strong evidence was assigne

…
244 results